ArticleCancer imaging : the official publication of the International Cancer Imaging Society2026
CT-based radiomics as a non-invasive virtual biopsy for high PD-L1 expression prediction in non-small cell lung cancer.
Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeNon-small cell lung cancer (NSCLC) remains a major clinical challenge, with Programmed death-ligand 1 (PD-L1) expression serving as a crucial biomarker to guide immunotherapy. However, its current assessment through invasive biopsies may not capture tumor heterogeneity. This study explores the feasibility of a CT-based radiomics approach, combined with machine learning (ML), as a potential non-invasive virtual biopsy to predict high PD-L1 expression (≥50%) in NSCLC patients.
methodsContrast-enhanced CT scans from 55 patients with histologically confirmed NSCLC were retrospectively analyzed. Radiomic features were extracted from tumor volumes, and multiple ML classifiers were trained and evaluated through repeated stratified k-fold cross-validation.
resultsAmong the models evaluated, the Support Vector Machine (SVM) classifier demonstrated the best performance, achieving a median accuracy of 0.77 (quartiles: 0.66-0.82) and an area under the curve (AUC) of 0.83 (0.63-0.92). Feature importance analysis using SHAP (Shapley Additive Explanations) revealed that texture features were the most informative in predicting PD-L1 expression levels. Notably, the integration of clinical data did not improve model performance, highlighting the dominant predictive value of radiomic features alone.
conclusionOur findings support the feasibility of CT-based radiomics as a potential tool for virtual biopsy to identify NSCLC patients with high PD-L1 expression (≥50%), potentially serving as a complementary or alternative tool to tissue biopsy, especially in cases where biopsy is contraindicated or insufficient.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.